The United Laboratories International Holdings Limited (SEHK: 3933)
Health Care · Pharmaceuticals · HK
HK$8.84
-1.23% today · -47.4% 1Y
The United Laboratories International Holdings Limited (SEHK: 3933) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $2.22B and employs 18,000 people.
Over the last twelve months the share price has lost 47.4%, trading between 7.98 and 17.97.
Tweenvest scores The United Laboratories International Holdings Limited across four factors: quality 86/100, value 51/100, growth 66/100, dividend 90/100. Its strongest factor is dividend.
3933 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.22B
- Revenue (TTM)
- $1.89B
- P/E
- 7.18
- EPS
- 1.11
- Dividend yield
- 5.47%
- Beta (5Y)
- 0.30
- 52-week high
- HK$17.97
- 52-week low
- HK$7.98
- Avg volume (3M)
- —
- Shares outstanding
- 1.97B
- Employees
- 18,000
- Next earnings
- —
About The United Laboratories International Holdings Limited
The United Laboratories International Holdings Limited functions as an investment holding company with a primary focus on the pharmaceutical sector. Its multifaceted operations cover the entire lifecycle of drug development and commercialization, from pioneering research and development to manufacturing, distribution, and sales. The company structures its diverse business into three core divisions: Bulk Medicine, Intermediate Products, and Finished Goods. Its broad product portfolio features a variety of medications, such as oral antibiotics, injectable antimicrobials, cold and cough remedies, ophthalmic solutions, antiviral and anti-hepatitis B drugs, diabetes treatments, topical dermatological preparations, cardiovascular and neurological pharmaceuticals, vitamins, and empty gelatin capsules, alongside active pharmaceutical ingredients (APIs) and other intermediary compounds. Furthermore, the company manufactures and markets soft capsule shells, holds trademarks, engages in pharmaceutical trading, and provides management services. Founded in 1990 and headquartered in Yuen Long, Hong Kong, the firm maintains a significant global reach, conducting business throughout the People's Republic of China, Europe, India, the Middle East, South America, other Asian territories, and internationally.
- ISIN
- KYG8813K1085
- Founded
- 1990
- Listed since
- Jun 15, 2007
- Exchange
- The Stock Exchange of Hong Kong Ltd.
- Currency
- HKD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,233.66 | -1.06% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $273.14 | +0.04% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $156.45 | +3.84% |
| Roche Holding AGSWX: ROP | $371.62B | CHF373.80 | +0.92% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £124.76 | +3.02% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.57 | +2.15% |
Figures last refreshed Aug 18, 2026.